Cytokinetics ROI - Return on Investment 2010-2024 | CYTK

Cytokinetics return on investment for the quarter ending September 30, 2024 was -127.23.

  • Cytokinetics average return on investment for 2023 was -144.44, a 87.29% decline from 2022.
  • Cytokinetics average return on investment for 2022 was -77.12, a 1.39% increase from 2021.
  • Cytokinetics average return on investment for 2021 was -78.21, a 43.83% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Cytokinetics ROI - Return on Investment 2010-2024 | CYTK

  • Cytokinetics average return on investment for 2023 was -144.44, a 87.29% decline from 2022.
  • Cytokinetics average return on investment for 2022 was -77.12, a 1.39% increase from 2021.
  • Cytokinetics average return on investment for 2021 was -78.21, a 43.83% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.